Neurological Complications at Stroke Patients With Diabetes Mellitus (SDM)
It is to be investigated if a correlation exist between the development of the HbA1c value and the complication rate is following a stroke.
|Study Design:||Observational Model: Case Control
Time Perspective: Prospective
|Official Title:||Neurological Complications at Stroke Patients With Diabetes Mellitus During the First Six Months After a Cerebral Ischemia|
- Functional outcome six months after the cerebral ischemia [ Time Frame: six months ] [ Designated as safety issue: No ]Functional outcome for the National Institutes of Health Stroke scale, the Barthel Index and Modified Ranking Scala six months after the cerebral ischemia.
- Additional cerebral ischemia [ Time Frame: six months ] [ Designated as safety issue: No ]Additional cerebral ischemia six months after the first cerebral ischemia
- Mortality [ Time Frame: sixt months ] [ Designated as safety issue: No ]Mortality in the first 6 months after the primary cerebral ischemia
|Study Start Date:||August 2010|
|Study Completion Date:||March 2011|
|Primary Completion Date:||March 2011 (Final data collection date for primary outcome measure)|
HbA1c ≤ 7
Stroke patients with mild diabetes mellitus HbA1c ≤ 7
HbA1c ≥ 7,5
Stroke patients with severe diabetes mellitus HbA1c ≥ 7,5
The immediate objective of the study is to find out if a correlation between blood sugar control in diabetics and the incidence of complications after a stroke exists.
The study has a high practical importance because any consequences in the treatment of diabetes mellitus can be implemented without affecting costs.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01172977
|Bielefeld, Germany, 33167|
|Principal Investigator:||Cristian Barzu, MD||Evangelisches Krankenhaus Bielefeld, Germany|